Bcl-2 pathway inhibition in solid tumors: a review of clinical trials.

Clin Transl Oncol · 2023 · PMC10203027 · PMID 36639602

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In conclusion, AT-101 was well-tolerated in all combination treatments, but in most studies improvement in primary endpoints did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.